DR. PATTY L. TENOFSKY, MD

WICHITA, KS

Research Active
Surgery NPI registered 21+ years 1 publication 2026 – 2026 NPI: 1992702328
Surgery

Practice Location

1947 N FOUNDERS CIR
WICHITA, KS 67206-3548

Phone: (316) 613-4047

What does PATTY TENOFSKY research?

Dr. Tenofsky studies the importance of genetic testing for breast cancer patients. Genetic testing can provide critical information about a person's risk of developing breast cancer and guide treatment options. Her research compares the effectiveness of having surgeons offer genetic testing directly in their clinics versus referring patients to genetic specialists. This is important as it can help more patients understand their risks and make informed decisions about their health and that of their families.

Key findings

  • In a study of 732 breast cancer patients, 62% completed genetic testing when offered by a surgeon.
  • Completion rates increased to 72.6% when testing was offered directly in the clinic by the surgeon.
  • Only 55.2% of patients completed genetic testing when referred to a genetic specialist.

Frequently asked questions

Does Dr. Tenofsky study breast cancer?
Yes, she focuses on breast cancer patients and their access to genetic testing.
What treatments has Dr. Tenofsky researched?
While Dr. Tenofsky primarily examines genetic testing, this information can help guide treatment decisions for breast cancer.
Is Dr. Tenofsky's work relevant to my family?
Yes, her research helps identify at-risk family members through improved genetic testing, which can benefit entire families.

Publications in plain English

Comparing Genetic Testing Completion among Breast Cancer Patients When Ordered by a Surgeon Versus a Genetic Specialist.

2026

Kansas journal of medicine

Kenas W, Ablah E, Okut H, Zackula R, Reyes J +3 more

Plain English
This study looked at how breast cancer patients completed genetic testing when it was offered directly by their surgeon compared to when they were referred to a genetic specialist. Among 732 women, 62% completed the testing, but this jumped to 72.6% when offered by the surgeon in the clinic, compared to 55.2% for referrals. This matters because higher completion rates can lead to better treatment decisions and earlier identification of at-risk family members. Who this helps: This helps breast cancer patients and their families by improving access to important genetic information.

PubMed

Frequent Co-Authors

Will Kenas Elizabeth Ablah Hayrettin Okut Rosey Zackula Jared Reyes Marshall Clune Grant Christiansen

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.